| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Editorials |
From the Division of Cardiology, Department of Medicine, University of California San Diego, La Jolla; and Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Multimedica, Milan, Italy.
Correspondence to Gianluigi Condorelli, Division of Cardiology, Department of Medicine, University of California San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0734. E-mail gcondorelli@ucsd.edu
See related article, pages 381388
Key Words: Akt stem cell signaling cardiomyocytes hypertrophy
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
"Akt quisque ipse faber fortunae suae... " (Each Akt makes its own destiny....)
During the last few years, Akt (protein kinase B [PKB]) has become among the most studied signal-transduction molecules in cardiac biology. Akt is, in fact, at the crossroads of the insulin- and insulin-like growth factor-1 (IGF-1)activated signal-transduction pathways. After insulin or IGF-1 interacts with its respective receptor, phosphatidylinositol 3-kinase (PI3K) phosphorylates inositol lipids that then bind to the pleckstrin domain of Akt, inducing its translocation to the plasma membrane. Here, Akt becomes the substrate of 3'-phosphoinositide-dependent kinase-1 (PDK-1), which activates it through phosphorylation of Thr308. Once active, Akt phosphorylates a number of "effector" substrates throughout the cell after migrating to subcellular organelles, including nuclei and mitochondria and other cytosolic locations. Therefore, the regulation of specific cellular functions is exerted by Akt at the level of the plasma membrane, nucleus, mitochondria, and cytosol in multiprotein complexes (Figure).
| |||||||||||
Models for studying the role of Akt, or its upstream molecules, in cardiac biology include cardiac-specific transgenic and knockout mice. Akt harboring mutations in either its pleckstrin or kinase domain, or containing
Related Article:
Circ. Res. 2006 99: 381-388.
This article has been cited by other articles:
![]() |
D. Catalucci, M. V. G. Latronico, M. Ceci, F. Rusconi, H. S. Young, P. Gallo, M. Santonastasi, A. Bellacosa, J. H. Brown, and G. Condorelli Akt Increases Sarcoplasmic Reticulum Ca2+ Cycling by Direct Phosphorylation of Phospholamban at Thr17 J. Biol. Chem., October 9, 2009; 284(41): 28180 - 28187. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Y. Oudit and J. M. Penninger Cardiac regulation by phosphoinositide 3-kinases and PTEN Cardiovasc Res, May 1, 2009; 82(2): 250 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Miyamoto, M. Rubio, and M. A. Sussman Nuclear and mitochondrial signalling Akts in cardiomyocytes Cardiovasc Res, May 1, 2009; 82(2): 272 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Catalucci, D.-H. Zhang, J. DeSantiago, F. Aimond, G. Barbara, J. Chemin, D. Bonci, E. Picht, F. Rusconi, N. D. Dalton, et al. Akt regulates L-type Ca2+ channel activity by modulating Cav{alpha}1 protein stability J. Cell Biol., March 23, 2009; 184(6): 923 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Caporali and C. Emanueli Cardiovascular Actions of Neurotrophins Physiol Rev, January 1, 2009; 89(1): 279 - 308. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |